DNAnexus Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 259

Employees

  • Latest Deal Type
  • Series I

  • Latest Deal Amount
  • $200M

  • Investors
  • 21

DNAnexus General Information

Description

Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company's platform assists researchers across a spectrum of industries like biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia to accelerate their genomics programs globally, enabling commercial and academic medical researchers to visualize and analyze big data systems for DNA from a single, unified system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Corporate Office
  • 1975 West El Camino Real
  • Suite 204
  • Mountain View, CA 94040
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DNAnexus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series I) 08-Mar-2022 $200M 00000 00000 Completed Generating Revenue
10. Later Stage VC (Series G) 06-Feb-2019 00000 00000 00000 Completed Generating Revenue
9. Later Stage VC (Series F) 02-Jan-2018 0000 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series E) 0000 000.00 00000 Completed Generating Revenue
7. Debt - General 01-May-2017 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 22-Apr-2015 0000 000.00 0000 Completed Generating Revenue
5. Debt - General 21-Mar-2014 000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 03-Jan-2014 0000 000.00 0000 Completed Startup
3. Early Stage VC (Series B) 12-Oct-2011 $15.2M $16.7M 000.00 Completed Startup
2. Early Stage VC (Series A) 28-Jul-2009 $1.55M $1.55M 00.000 Completed Startup
To view DNAnexus’s complete valuation and funding history, request access »

DNAnexus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series I 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series H 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series G 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series F-2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series F-1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series E 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.00
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 7,559,292 $0.001000 $0.16 $2.02 $2.02 1x $0.63 2.37%
Series A 1,347,823 $0.001000 $0.09 $1.15 $1.15 1x $0.47 0.32%
To view DNAnexus’s complete cap table history, request access »

DNAnexus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company'
Discovery Tools (Healthcare)
Mountain View, CA
259 As of 2023
00000
0000 0000-00-00
00000000000 00000

000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
00000 0000000000 000
Rolle, Switzerland
000 As of 0000
00000
000000000 00000

000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
00000 0000000000 000
Foster City, CA
000 As of 0000
00.000
000000000 - 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DNAnexus Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SOPHiA GENETICS Formerly VC-backed Rolle, Switzerland 000 00000 000000000 00000
PointCross Life Sciences Venture Capital-Backed Foster City, CA 000 00.000 000000000 - 00.000
Genuity Science Formerly VC-backed Boston, MA 000 00000 000000&0 00000
Genomenon Venture Capital-Backed Ann Arbor, MI 00 000.00 00000000000 000.00
Second Genome Venture Capital-Backed Brisbane, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 37 competitors. Get the full list »

DNAnexus Patents

DNAnexus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170237805-A1 Worker reuse deadline Inactive 12-Feb-2016 0000000000
US-20170177597-A1 Biological data systems Inactive 22-Dec-2015
US-20140249761-A1 Characterizing uncharacterized genetic mutations Inactive 01-Mar-2013 000000000 0
US-20150331909-A1 Application programming interface for tabular genomic datasets Inactive 20-Dec-2012 0
US-20140244625-A1 Sequence read archive interface Inactive 12-Aug-2011 G16B50/00 0
To view DNAnexus’s complete patent history, request access »

DNAnexus Executive Team (26)

Name Title Board Seat Contact Info
Thomas Laur Chief Executive Officer & Board Member
John Ellithorpe Ph.D President
James McNicholas Chief Financial Officer
George Asimenos Ph.D Chief Technology Officer
Kelly Green Chief People Officer
You’re viewing 5 of 26 executive team members. Get the full list »

DNAnexus Board Members (18)

Name Representing Role Since
Edward Hu Ph.D WuXi Healthcare Ventures Board Member 000 0000
Ge Li Ph.D WuXi Healthcare Ventures Board Member 000 0000
Geoffrey Duyk Ph.D Self Board Member 000 0000
Hannes Smarason Genuity Science Board Member 000 0000
James Tananbaum MD Foresite Capital Board Member 000 0000
You’re viewing 5 of 18 board members. Get the full list »

DNAnexus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DNAnexus Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Blackstone PE/Buyout Minority 000 0000 000000 0
Northpond Ventures Venture Capital Minority 000 0000 000000 0
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0
Innovatus Capital Partners Asset Manager Minority 000 0000 000000 0
Foresite Capital Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »